CD8A and neoplasm: Unmodified OVA-LNPs significantly reduced tumor growth, prolonged survival, and increased intratumoural CD40+ DCs and the frequency of granzyme B+/IFN-g+/TNF-a+ polyfunctional OVA peptide-specific CD8+ T cells in a B16-OVA murine melanoma model.